Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Multiple sclerosis
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Epidemiology == {{Update|section|date=July 2022}} [[File:Multiple sclerosis world map-Deaths per million persons-WHO2012.svg|thumb|left|upright=1.3|Deaths from multiple sclerosis per million persons in 2012 {{Div col|small=yes|colwidth=10em}}{{legend|#ffff20|0}}{{legend|#ffc020|1}}{{legend|#f08015|2}}{{legend|#e06815|3β5}}{{legend|#d85010|6β12}}{{legend|#d02010|13β25}}{{div col end}}]] MS is the most common autoimmune disorder of the central nervous system.<ref name="pmid24746689" /> The latest estimation of the total number of people with MS was 2.8 million globally, with a [[prevalence]] of 36 per 100,000 people. Moreover, prevalence varies widely in different regions around the world.<ref name="Lane2022" /> In Africa, there are five people per 100,000 diagnosed with MS, compared to South East Asia where the prevalence is nine per 100,000, 112 per 100,000 in the Americas, and 133 per 100,000 in Europe.<ref>{{Cite web | work = Multiple Sclerosis International Federation |date=September 2020 |title=Atlas of MS |url=https://www.msif.org/wp-content/uploads/2020/12/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf}}</ref> Nearly one million people in the United States had MS in 2022.<ref name="McGinley2021">{{cite journal |vauthors=McGinley MP, Goldschmidt CH, Rae-Grant AD |title=Diagnosis and Treatment of Multiple Sclerosis: A Review |journal=JAMA |volume=325 |issue=8 |pages=765β779 |date=February 2021 |pmid=33620411 |doi=10.1001/jama.2020.26858|s2cid=232019589 }}</ref> Increasing rates of MS may be explained simply by better diagnosis.<ref name=Milo2010 /> Studies on populational and [[#Geography|geographical patterns]] have been common<ref name="pmid8269393">{{cite journal | vauthors = Kurtzke JF | title = Epidemiologic evidence for multiple sclerosis as an infection | journal = Clinical Microbiology Reviews | volume = 6 | issue = 4 | pages = 382β427 | date = October 1993 | pmid = 8269393 | pmc = 358295 | doi = 10.1128/CMR.6.4.382 }}</ref> and have led to a number of theories about the cause.<ref name="Ascherio_2007"/><ref name="pmid15556803">{{cite journal | vauthors = Marrie RA | title = Environmental risk factors in multiple sclerosis aetiology | journal = The Lancet. Neurology | volume = 3 | issue = 12 | pages = 709β18 | date = December 2004 | pmid = 15556803 | doi = 10.1016/S1474-4422(04)00933-0 | s2cid = 175786 }}</ref><ref name="pmid17492755">{{cite journal | vauthors = Ascherio A, Munger KL | title = Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors | journal = Annals of Neurology | volume = 61 | issue = 6 | pages = 504β13 | date = June 2007 | pmid = 17492755 | doi = 10.1002/ana.21141 | s2cid = 36999504 | doi-access = free }}</ref> MS usually appears in adults in their late twenties or early thirties but it can rarely start in childhood and after 50 years of age.<ref name=Milo2010 /><ref name=Atlas2008 /> The primary progressive subtype is more common in people in their fifties.<ref name="pmid17884680" /> Similarly to many autoimmune disorders, the disease is more common in women, and the trend may be increasing.<ref name="pmid1897097722"/><ref name="pmid18606967">{{cite journal | vauthors = Alonso A, HernΓ‘n MA | title = Temporal trends in the incidence of multiple sclerosis: a systematic review | journal = Neurology | volume = 71 | issue = 2 | pages = 129β135 | date = July 2008 | pmid = 18606967 | pmc = 4109189 | doi = 10.1212/01.wnl.0000316802.35974.34 }}</ref> As of 2020, globally it is about two times more common in women than in men, and the ratio of women to men with MS is as high as 4:1 in some countries.<ref>{{cite journal | vauthors = Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P | title = Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition | journal = Multiple Sclerosis | volume = 26 | issue = 14 | pages = 1816β1821 | date = December 2020 | pmid = 33174475 | pmc = 7720355 | doi = 10.1177/1352458520970841 }}</ref> In children, it is even more common in females than males,<ref name="pmid1897097722"/> while in people over fifty, it affects males and females almost equally.<ref name="pmid17884680" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)